Clinical Trial Update: Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/2 study evaluating infusion of allogeneic bone marrow mesenchymal stem cells for steroid-refractory graf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Allogeneic bone marrow mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED